Grifols SA (GRFS)
6.54
-0.04
(-0.61%)
USD |
NASDAQ |
Apr 18, 16:00
6.535
0.00 (0.00%)
After-Hours: 20:00
Grifols Price: 6.54 for April 18, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 18, 2024 | 6.64 | 6.64 | 6.46 | 6.54 | 760141.0 |
| Apr 17, 2024 | 6.84 | 6.84 | 6.48 | 6.58 | 1.460M |
| Apr 16, 2024 | 6.51 | 6.80 | 6.44 | 6.78 | 1.535M |
| Apr 15, 2024 | 6.57 | 6.70 | 6.47 | 6.54 | 1.317M |
| Apr 12, 2024 | 6.57 | 6.63 | 6.49 | 6.56 | 938741.0 |
| Apr 11, 2024 | 6.65 | 6.72 | 6.56 | 6.65 | 1.165M |
| Apr 10, 2024 | 6.71 | 7.02 | 6.71 | 6.97 | 1.420M |
| Apr 09, 2024 | 7.29 | 7.35 | 7.13 | 7.18 | 1.875M |
| Apr 08, 2024 | 7.18 | 7.325 | 7.14 | 7.29 | 1.757M |
| Apr 05, 2024 | 7.00 | 7.130 | 6.885 | 7.09 | 1.021M |
| Apr 04, 2024 | 6.95 | 7.07 | 6.86 | 6.86 | 1.643M |
| Apr 03, 2024 | 6.72 | 6.91 | 6.65 | 6.89 | 2.068M |
| Apr 02, 2024 | 6.54 | 6.80 | 6.41 | 6.78 | 1.177M |
| Apr 01, 2024 | 6.70 | 6.70 | 6.55 | 6.68 | 494658.0 |
| Mar 28, 2024 | 6.58 | 6.70 | 6.50 | 6.68 | 1.026M |
| Mar 27, 2024 | 6.52 | 6.67 | 6.44 | 6.65 | 950032.0 |
| Mar 26, 2024 | 6.45 | 6.48 | 6.39 | 6.48 | 1.401M |
| Mar 25, 2024 | 6.31 | 6.45 | 6.25 | 6.36 | 1.580M |
| Mar 22, 2024 | 6.14 | 6.22 | 5.95 | 6.22 | 2.990M |
| Mar 21, 2024 | 6.38 | 6.82 | 5.80 | 6.78 | 5.885M |
| Mar 20, 2024 | 6.15 | 6.32 | 6.09 | 6.29 | 2.133M |
| Mar 19, 2024 | 5.97 | 6.14 | 5.94 | 6.06 | 2.283M |
| Mar 18, 2024 | 6.07 | 6.07 | 5.93 | 6.05 | 2.074M |
| Mar 15, 2024 | 5.91 | 6.18 | 5.85 | 6.13 | 3.767M |
| Mar 14, 2024 | 5.78 | 5.90 | 5.68 | 5.76 | 3.906M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
5.47
Minimum
Mar 06 2024
25.63
Maximum
Feb 21 2020
14.22
Average
13.84
Median
Price Benchmarks
| DBV Technologies SA | 0.661 |
| Adaptimmune Therapeutics PLC | 0.8984 |
| Biodexa Pharmaceuticals Plc | 0.8201 |
| NuCana PLC | 3.97 |
| Autolus Therapeutics PLC | 4.795 |
Price Related Metrics
| PE Ratio | 21.02 |
| PS Ratio | 0.6158 |
| Price to Book Value | 0.685 |
| Earnings Yield | 4.76% |
| Market Cap | 4.441B |
| Operating PE Ratio | 5.525 |
| Normalized PE Ratio | 30.68 |